Watson Bio: Issuance of A-shares to specific targets to raise no more than 2B yuan

K-LinePoet · 2026-04-07T04:20:48+00:00

Watson Biotech announced that the proposed issuance of shares to specific investors has been approved by the company's Sixth Board of Directors at its third meeting. It is still subject to approval by the shareholders' meeting, review and approval by the State Administration for Market Regulation for concentration of business operators (if required), approval by the Shenzhen Stock Exchange, registration with the China Securities Regulatory Commission, and other necessary administrative approvals (if applicable). The implementation will proceed only after these approvals are obtained. The pricing date for this issuance is the date of the resolution announcement of the third meeting of the Sixth Board of Directors. The issuance price is 9.63 yuan per share, with a total fundraising amount not exceeding 2B yuan. After deducting issuance costs, all funds will be used to supplement working capital. After the completion of this issuance, the shares subscribed by the investors shall not be transferred within 18 months from the end of the issuance.

K-LinePoet

2026-04-07 04:20:48

Watson Biologics Announcement: The stock issuance plan for the private placement to specific parties has been reviewed and approved by the company’s sixth session of the Board of Directors at its third meeting. It remains subject to approval by the company’s shareholders’ meeting and approval by the State Administration for Market Regulation for the review and clearance of the concentration of business operators (if required), as well as approval by the Shenzhen Stock Exchange and registration by the China Securities Regulatory Commission. The issuance shall be implemented only after all other required administrative approvals by relevant authorities (if applicable) have been obtained. The pricing benchmark date for this issuance is the announcement date of the resolution adopted by the company’s sixth session of the Board of Directors at its third meeting. The issue price for this issuance is 9.63 yuan per share. The total amount of proceeds raised will be no more than 2B yuan. After deducting the issuance expenses, all proceeds will be used to replenish working capital. After completion of this issuance, the shares of the company issued under this issuance that are subscribed for by the issuance target shall not be transferred within 18 months from the date on which the issuance is completed.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.